D&D Pharmatech Soars on MASH Data, Tomocube Rallies on Organoid Hopes[K-bio pulse] 송영두 2025.06.17 오전 08:08 Celltrion biosimilars expand dominance in Japan’s oncology market 임정요 2025.06.13 오전 10:11 Botox Controversy Exposes K-Bio’s Fragile Core 류성 2025.06.12 오전 08:20 BioSolution, Hainan Officials Explore China Entry Strategy 석지헌 2025.06.25 오전 11:27 "Why Bio Spinoff IPOs Are So Prevalent" 류성 2025.06.25 오전 10:41 Market Reacts to Biotech Extremes: HLB Therapeutics Collapses, Abion Soars[K-Bio Pulse] 나은경 2025.06.25 오전 07:45 BridgeBio Soars; Lunit Gains on AI Policy Hopes[K-bio pulse] 김진수 2025.06.24 오전 07:47 동성제약, 177억원 횡령 혐의…불성실공시법인 지정예고까지 김진수 2025.06.25 오후 04:36 박재홍 동아에스티 사장 "신약개발로 L/O 총력...3세대 ADC로 승부" 김승권 2025.06.25 오전 08:01 Bridgebio, Escapes Delisting Crisis, Transforms into Bitcoin company[K-Bio Pulse] 김지완 2025.06.23 오전 07:58 더 보기 로딩중..
S-
S-
![D&D Pharmatech Soars on MASH Data, Tomocube Rallies on Organoid Hopes[K-bio pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/06/PS25061700489b.jpg)
![Market Reacts to Biotech Extremes: HLB Therapeutics Collapses, Abion Soars[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/06/PS25062500205b.jpg)
![BridgeBio Soars; Lunit Gains on AI Policy Hopes[K-bio pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/06/PS25062400105b.jpg)
![Bridgebio, Escapes Delisting Crisis, Transforms into Bitcoin company[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/06/PS25062300155b.jpg)